MedTrace Logo

Therapeutic Endometrial Biopsy

NCT01963819 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2018-03-19

No results posted yet for this study

Summary

The aim of this study is to evaluate the potential benefits in implantation, clinical pregnancy and live birth rates by an endometrial biopsy prior to an IVF/ICSI treatment. Including a follow up on possible pregnancy complications and data on children at birth.

Further it is planned to aspirate secretions from the uterus and take blood samples during the treatment, which presumably can provide information about the mechanisms underlying the possible effect of the treatment.

Conditions

Interventions

OTHER

Endometrial biopsy

The endometrial biopsy will be done in the luteal phase (cycle day 18-22) prior to the treatment cycle (antagonist)

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Axel Forman, MD, DMsc · Departement of Gynaecology and Obstetrics, Aarhus University Hospital, Skejby

  • Inge E Agerholm, M.Sc, PhD · Fertility Clinic, Horsens Hospital

  • Benedicte Hauge, MD · Fertility Clinic, Horsens Hospital

  • Peter Humaidan, MD, DMSc · Fertility Clinic, Skive Hospital

  • Mia Steengaard Olesen, MD · Fertility Clinic Horsens Hospital, Aarhus University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01963819 on ClinicalTrials.gov